These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38051386)

  • 21. Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP).
    Limongelli G; Adorisio R; Baggio C; Bauce B; Biagini E; Castelletti S; Favilli S; Imazio M; Lioncino M; Merlo M; Monda E; Olivotto I; Parisi V; Pelliccia F; Basso C; Sinagra G; Indolfi C; Autore C; ;
    Int J Cardiol; 2022 Jun; 357():55-71. PubMed ID: 35364138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MOGE(S) classification : A TNM-like classification for cardiomyopathies.
    Şahan E; Şahan S; Karamanlıoğlu M; Gul M; Tufekcioğlu O
    Herz; 2016 Sep; 41(6):503-6. PubMed ID: 26809453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study.
    Rowin EJ; Maron MS; Adler A; Albano AJ; Varnava AM; Spears D; Marsy D; Heitner SB; Cohen E; Leong KMW; Winters SL; Martinez MW; Koethe BC; Rakowski H; Maron BJ
    Heart Rhythm; 2022 May; 19(5):782-789. PubMed ID: 34933112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NAM; Cooper LT; Link MS; Maron MS
    J Am Coll Cardiol; 2015 Dec; 66(21):2362-2371. PubMed ID: 26542657
    [No Abstract]   [Full Text] [Related]  

  • 25. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].
    ; Elliott PM; Anastasakis A; Borger MA; Borggrefe M; Cecchi F; Charron P; Hagege AA; Lafont A; Limongelli G; Mahrholdt H; McKenna WJ; Mogensen J; Nihoyannopoulos P; Nistri S; Pieper PG; Pieske B; Rapezzi C; Rutten FH; Tillmanns C; Watkins H
    Kardiol Pol; 2014; 72(11):1054-126. PubMed ID: 25524376
    [No Abstract]   [Full Text] [Related]  

  • 26. Preoperative preparation of patients with cardiomyopathies in non-cardiac surgery.
    Bradić Z; Ivanović B; Marković D; Simić D; Janković R; Kalezić N
    Acta Chir Iugosl; 2011; 58(2):39-43. PubMed ID: 21879649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy.
    Leong KMW; Chow JJ; Ng FS; Falaschetti E; Qureshi N; Koa-Wing M; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Lim PB; Peters NS; Kanagaratnam P; Varnava AM
    Am J Cardiol; 2018 Feb; 121(3):349-355. PubMed ID: 29203036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM.
    Kittleson MD; Côté E
    J Feline Med Surg; 2021 Nov; 23(11):1053-1067. PubMed ID: 34693805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical practice guidelines for hereditary cardiomyopathy].
    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Sun J; Han S; Hu J; Jiang C; Wang Q; Zheng L; Zhou Z; Qi M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):300-307. PubMed ID: 32128748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic work-up and clinical management of cardiomyopathies: the operative protocol from the Cardiothoracovascular Department of Trieste, Italy].
    Merlo M; Cappelletto C; De Angelis G; Porcari A; Caiffa T; Lardieri G; Pagnan L; Severini GM; Dal Ferro M; Stolfo D; Vitrella G; De Luca A; Korkova R; Massa L; Tavcˇar I; Aleksova A; Barbati G; Zanchi C; Ramani F; Di Lenarda A; Perkan A; Mestroni L; Zecchin M; Pinamonti B; Bussani R; Sinagra G
    G Ital Cardiol (Rome); 2020 Dec; 21(12):935-953. PubMed ID: 33231213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new 2023 ESC guidelines for the management of cardiomyopathies: a guiding path for cardiologist decisions.
    Grasso M; Bondavalli D; Vilardo V; Cavaliere C; Gatti I; Di Toro A; Giuliani L; Urtis M; Ferrari M; Cattadori B; Serio A; Pellegrini C; Arbustini E
    Eur Heart J Suppl; 2024 Apr; 26(Suppl 1):i1-i5. PubMed ID: 38867869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).
    O'Mahony C; Jichi F; Ommen SR; Christiaans I; Arbustini E; Garcia-Pavia P; Cecchi F; Olivotto I; Kitaoka H; Gotsman I; Carr-White G; Mogensen J; Antoniades L; Mohiddin SA; Maurer MS; Tang HC; Geske JB; Siontis KC; Mahmoud KD; Vermeer A; Wilde A; Favalli V; Guttmann OP; Gallego-Delgado M; Dominguez F; Tanini I; Kubo T; Keren A; Bueser T; Waters S; Issa IF; Malcolmson J; Burns T; Sekhri N; Hoeger CW; Omar RZ; Elliott PM
    Circulation; 2018 Mar; 137(10):1015-1023. PubMed ID: 29191938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team.
    Pelliccia F; Alfieri O; Calabrò P; Cecchi F; Ferrazzi P; Gragnano F; Kaski JP; Limongelli G; Maron M; Rapezzi C; Seggewiss H; Yacoub MH; Olivotto I
    Int J Cardiol; 2020 Apr; 304():86-92. PubMed ID: 31983465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Congenital heart diseases in adult age and primary cardiomyopathies at the referral centers].
    Dolara A
    Minerva Cardioangiol; 2004 Aug; 52(4):345-6. PubMed ID: 15284684
    [No Abstract]   [Full Text] [Related]  

  • 35. ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats.
    Luis Fuentes V; Abbott J; Chetboul V; Côté E; Fox PR; Häggström J; Kittleson MD; Schober K; Stern JA
    J Vet Intern Med; 2020 May; 34(3):1062-1077. PubMed ID: 32243654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan: Reconciling the American and European Approaches.
    Al Samarraie A; Petzl A; Cadrin-Tourigny J; Tadros R
    Card Electrophysiol Clin; 2023 Sep; 15(3):367-378. PubMed ID: 37558306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy.
    Norrish G; Ding T; Field E; McLeod K; Ilina M; Stuart G; Bhole V; Uzun O; Brown E; Daubeney PEF; Lota A; Linter K; Mathur S; Bharucha T; Kok KL; Adwani S; Jones CB; Reinhardt Z; Omar RZ; Kaski JP
    Europace; 2019 Oct; 21(10):1559-1565. PubMed ID: 31155643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry.
    Mizia-Stec K; Charron P; Gimeno Blanes JR; Elliott P; Kaski JP; Maggioni AP; Tavazzi L; Tendera M; Felix SB; Dominguez F; Ojrzynska N; Losi MA; Limongelli G; Barriales-Villa R; Seferovic PM; Biagini E; Wybraniec M; Laroche C; Caforio ALP;
    Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):781-789. PubMed ID: 33417664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiomyopathies II. Hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy].
    Schultheiss HP; Noutsias M; Kühl U; Gross U; Lassner D; Poller W; Pauschinger M
    Internist (Berl); 2005 Dec; 46(12):1373-85, quiz 1386-7. PubMed ID: 16237514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
    ; Elliott PM; Anastasakis A; Borger MA; Borggrefe M; Cecchi F; Charron P; Hagege AA; Lafont A; Limongelli G; Mahrholdt H; McKenna WJ; Mogensen J; Nihoyannopoulos P; Nistri S; Pieper PG; Pieske B; Rapezzi C; Rutten FH; Tillmanns C; Watkins H
    Eur Heart J; 2014 Oct; 35(39):2733-79. PubMed ID: 25173338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.